Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

NCT01061177 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1090

Enrollment

INDUSTRY

Sponsor class

Conditions

CML in Chronic Phase

Interventions

DRUG: Nilotinib

Sponsor

Novartis Pharmaceuticals